Demexiptiline
{{Short description|Chemical compound}}
{{Drugbox
| IUPAC_name = 5H-dibenzo(a,d)cyclohepten-5-one O-(2-(methylamino)ethyl)oxime
| image = demexiptiline.png
| alt = Skeletal formula of demexiptiline
| width = 180
| image2 = Demexiptiline-3D-spacefill.png
| alt2 = Space-filling model of the demexiptiline molecule
| tradename = Deparon, Tinoran
| pregnancy_category =
| legal_status = Rx-only
| routes_of_administration = Oral
| bioavailability =
| metabolism =
| elimination_half-life = 35 hours{{cite book| vauthors = Dörwald FZ |title=Lead Optimization for Medicinal Chemists: Pharmacokinetic Properties of Functional Groups and Organic Compounds|url=https://books.google.com/books?id=YTeY9ZEfNccC&pg=PA313|date=4 February 2013|publisher=John Wiley & Sons|isbn=978-3-527-64565-7|pages=313–}}
| excretion =
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 24701-51-7
| ATC_prefix = none
| ATC_suffix =
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB08998
| PubChem = 28876
| ChEMBL = 2107576
| ChemSpiderID = 26858
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = EYX738UZ5P
| C=18 | H=18 | N=2 | O=1
| SMILES = O(\N=C3/c1ccccc1\C=C/c2c3cccc2)CCNC
}}
Demexiptiline (brand names Deparon, Tinoran) is a tricyclic antidepressant (TCA) used in France for the treatment of depression.{{cite book | author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000 | page = 301 | isbn = 3-88763-075-0 | url = https://books.google.com/books?id=5GpcTQD_L2oC&q=demexiptiline&pg=PA301}}{{cite book | vauthors = Triggle DJ | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | page = 583 | isbn = 0-412-46630-9 | url = https://books.google.com/books?id=DeX7jgInYFMC&q=demexiptiline&pg=RA1-PA583}} It acts primarily as a norepinephrine reuptake inhibitor similarly to desipramine.{{cite journal | vauthors = Teste JF, Pelsy-Johann I, Decelle T, Boulu RG | title = Anti-immobility activity of different antidepressant drugs using the tail suspension test in normal or reserpinized mice | journal = Fundamental & Clinical Pharmacology | volume = 7 | issue = 5 | pages = 219–26 | year = 1993 | pmid = 8370568 | doi = 10.1111/j.1472-8206.1993.tb00235.x| s2cid = 24240307 }}
Synthesis
The ketone dibenzosuberenone (1) is treated with hydroxylamine (2) to give its ketoxime (3). Base-catalyzed alkylation with {{chem2|ClCH2CH2NHCH3}} (4) yields demexiptiline.{{cite journal | vauthors = Aichinger G, Behner O, Hoffmeister F, Schütz S | title = Basic tricyclic oxyiminoethers and their pharmacological properties | journal = Arzneimittel-Forschung | volume = 19 | pages = Suppl 5a:838+ | date = June 1969 | pmid = 5819763 |language=DE }}{{cite patent |title=Basic oximes and their preparation | inventor = Schütz S, Behner O, Hoffmeister F | country = US | number = 3963778 | gdate = 1976-06-15 | assign1 = Bayer AG }}
References
{{Reflist|2}}
Further reading
{{refbegin}}
- {{cite journal | vauthors = Martin A, Masson JM, Jusseaume P, Beloncle M, Voisinet C | title = [Demexiptiline in the treatment of melancholic states (reflections after 3 years of use)] | language = fr | journal = Annales médico-psychologiques | volume = 139 | issue = 9 | pages = 1023–35 |date=November 1981 | pmid = 7337336}}
{{refend}}
{{Antidepressants}}
{{Navboxes
| title = Pharmacodynamics
| titlestyle = background:#ccccff
| list1 =
{{Adrenergic receptor modulators}}
{{Histamine receptor modulators}}
{{Monoamine reuptake inhibitors}}
{{Muscarinic acetylcholine receptor modulators}}
{{Serotonin receptor modulators}}
}}
{{Tricyclics}}
{{Use dmy dates|date=March 2018}}
Category:Tricyclic antidepressants
{{nervous-system-drug-stub}}